REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Innogen Pharmaceuticals, Inc. (Philippines)

Main Activities: Advertising Agencies
Full name: Innogen Pharmaceuticals, Inc. Profile Updated: January 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Innogen Pharmaceuticals, Inc. is a company in Philippines, with a head office in Quezon City. It operates in the Advertising Agencies industry. The company was established on February 05, 2007. From the latest financial highlights, Innogen Pharmaceuticals, Inc. reported a net sales revenue increase of 1.24% in 2024. There was a total growth of 0.69% in Innogen Pharmaceuticals, Inc.’s total assets over the same period. The enterprise’s net profit margin increased by 0.4% in 2024.

Headquarters
124-126, Dr. Lazcano St
Quezon City; National Capital Region;

Contact Details: Purchase the Innogen Pharmaceuticals, Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Innogen Pharmaceuticals, Inc. report to view the information.
Incorporation Date:
February 05, 2007
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Innogen Pharmaceuticals, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
1.24%▲
Total Operating Revenue
1.24%▲
Operating Profit
6.31%▲
EBITDA
7.15%▲
Net Profit/Loss for the Period
6.97%▲
Total Assets
0.69%▲
Total Equity
5.77%▲
Operating Profit Margin
0.29%▲
Net Profit Margin
0.4%▲
Return on Equity (ROE)
0.96%▲
Quick Ratio
0%
Cash Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo